fbpx
August 28, 2022

AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke

The new factor XI inhibitor antithrombotic, milvexian (BMS/Janssen), has shown promising results in a dose-finding phase 2 trial in patients with acute ischemic stroke or transient […]
August 28, 2022

ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease

Allopurinol, a drug commonly used to treat gout, provided no benefit in terms of reducing cardiovascular (CV) events in patients with ischemic heart disease, new randomized […]
August 27, 2022

Artificial Intelligence Beats Sonographers for Echo Accuracy Artificial Intelligence Beats Sonographers for Echo Accuracy

Video-based artificial intelligence provided a more accurate and consistent reading of echocardiograms than did experienced sonographers in a blinded trial, a result suggesting that this technology […]
August 27, 2022

Dapagliflozin’s HFpEF Benefit Recasts HF Treatment: DELIVER Dapagliflozin’s HFpEF Benefit Recasts HF Treatment: DELIVER

BARCELONA — The SGLT2 inhibitor dapagliflozin (Farxiga) became the third agent from the class to show evidence for efficacy in patients with heart failure with preserved ejection […]
August 27, 2022

DANCAVAS Hints at Benefit from Comprehensive CV Screening DANCAVAS Hints at Benefit from Comprehensive CV Screening

Comprehensive image-based cardiovascular screening in men aged 65-74 years did not significantly reduce all-cause mortality in a new Danish study, although there were strong suggestions of […]
August 27, 2022

PCI Fails to Beat OMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 PCI Fails to Beat OMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Percutaneous coronary intervention (PCI) with optimal medical therapy (OMT) does not prolong survival or improve ventricular function compared with OMT alone in patients with severe ischemic […]
August 27, 2022

Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR

A decades-old drug, added to standard loop diuretics, could potentially help more volume-overloaded patients with acute decompensated heart failure (ADHF) to be discharged from the hospital […]
August 26, 2022

Warfarin Associated With Higher UGIB Rates Compared With DOACs Warfarin Associated With Higher UGIB Rates Compared With DOACs

Warfarin is associated with higher rates of upper gastrointestinal (GI) bleeding but not overall or lower gastrointestinal bleeding rates compared with direct oral anticoagulants (DOACs), according […]
August 26, 2022

Noninvasive Cosmetic Procedures: Adverse Event Reports Reviewed Noninvasive Cosmetic Procedures: Adverse Event Reports Reviewed

Cryolipolysis accounted for a majority of noninvasive cosmetic procedures associated with adverse events, according to an analysis of data from the Manufacturer and User Facility Device Experience […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0